Commentary

Fouchier vs the Dutch government on influenza H5N1 research

From Martin Enserink at ScienceInsider: Virologist Ron Fouchier has suffered a loss in a legal battle with the Dutch government over the publication of his controversial H5N1 influenza research. On Friday, a Dutch district court ruled that the government was right to ask Fouchier to obtain an export license before sending two hotly debated papers …

Fouchier vs the Dutch government on influenza H5N1 research Read More »

Virologists plan influenza H7N9 gain of function experiments

A group of virologists lead by Yoshihiro Kawaoka and Ron Fouchier have sent a letter to Nature and Science outlining the experiments they propose to carry out with influenza H7N9 virus. Avian influenza H7N9 virus has caused over 130 human infections in China with 43 fatalities. The source of the virus is not known but …

Virologists plan influenza H7N9 gain of function experiments Read More »

Influenza H5N1 x H1N1 reassortants: ignore the headlines, it’s good science

Those of you with an interest in virology, or perhaps simply sensationalism, have probably seen the recent headlines proclaiming another laboratory-made killer influenza virus. From The Independent: ‘Appalling irresponsibility: Senior scientists attack Chinese researchers for creating new strains of influenza virus’; and from InSing.com: ‘Made-in-China killer flu virus’. It’s unfortunate that the comments of several …

Influenza H5N1 x H1N1 reassortants: ignore the headlines, it’s good science Read More »

Harvard University: Great virology, bad science writing

Harvard University is home to some of the world’s finest virologists. But apparently they do not communicate with the writers at Harvard Magazine, where a botched story on the avian H5N1 influenza virus has just been published. The problems begin with the first paragraph: But when Dutch researchers recently created an even more deadly strain …

Harvard University: Great virology, bad science writing Read More »

The risks and benefits of influenza H5N1 research

Both Nature and the New York Times have weighed in on the resumption of influenza H5N1 research. In an editorial from 23 January 2013, Nature opines that “Experiments that make deadly pathogens more dangerous demand the utmost scrutiny”: As several critics point out, the assessments of the relative risks and benefits of such research remain …

The risks and benefits of influenza H5N1 research Read More »

Scroll to Top